Effects of food and grapefruit juice on single-dose pharmacokinetics of blonanserin in healthy Chinese subjects

被引:15
作者
Shang, De-Wei [1 ]
Wang, Zhan-Zhang [1 ]
Hu, Hai-Tang [2 ]
Zhang, Yue-Feng [1 ]
Ni, Xiao-Jia [1 ]
Lu, Hao-Yang [1 ]
Zhang, Ming [1 ]
Hu, Jin-Qing [1 ]
Qiu, Chang [1 ]
Peng, Huan [1 ]
Shen, Ling-Fang [1 ]
Wen, Yu-Guan [1 ]
机构
[1] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, 36 Mingxin Rd, Guangzhou 510370, Guangdong, Peoples R China
[2] Livzon Pharmaceut Grp Co Ltd, Clin Res Ctr, 132 Guihua North Rd, Zhuhai 519020, Peoples R China
关键词
Blonanserin; N-desethyl blonanserin; Schizophrenia; Food/herbal drug interactions; Pharmacokinetics; DRUG-INTERACTIONS; VOLUNTEERS;
D O I
10.1007/s00228-017-2340-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to investigate the potential effects of a meal and grapefruit juice on the pharmacokinetics of blonanserin and its metabolite N-desethyl blonanserin in healthy Chinese volunteers. This was a single-centre, open-label, fixed-sequence study, where 12 healthy Chinese volunteers received a single dose of 8 mg blonanserin after an overnight fast in period 1 (reference), a high-fat meal during period 2 and with co-administration of 250 mL of grapefruit juice in period 3. The washout period was 7 days. Series of plasma samples were collected after each dose to determine concentrations of blonanserin and its metabolite N-desethyl blonanserin using liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were estimated by non-compartmental analysis and compared between periods by standard average bioequivalence ANOVA. Adverse events were monitored throughout the study. All subjects completed the study. High-fat meals significantly increased blonanserin exposure (AUC(t)) 2.58-fold (90% CI 2.21, 3.02), relative to the reference period. Co-administration of blonanserin with grapefruit juice remarkably prolonged elimination half-life of blonanserin (from 9.7 to 21.4 h) and significantly increased exposures to blonanserin and N-desethyl blonanserin by 5.82-fold (90% CI 4.57, 7.42) and 1.81-fold (90% CI 1.65, 1.98), respectively. These results suggested that blonanserin was largely metabolised in the intestinal tract before becoming systemically available, and both food and grapefruit juice enhanced exposure to blonanserin and N-desethyl blonanserin. Grapefruit juice increased bioavailability and may have reduced systemic clearance of blonanserin. Further intestinal CYP3A4 and hepatic CYP3A4 might be postulated to explain the delayed elimination of blonanserin. Dose adjustment of blonanserin is needed on the basis of co-intake of known strong CYP3A4 inhibitor. Patients taking high-dose blonanserin also need to be cautious about the ingestion of grapefruit juice.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 24 条
[1]   Food, gastrointestinal pH, and models of oral drug absorption [J].
Abuhelwa, Ahmad Y. ;
Williams, Desmond B. ;
Upton, Richard N. ;
Foster, David J. R. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 112 :234-248
[2]   Drug interactions with grapefruit juice [J].
Ameer, B ;
Weintraub, RA .
CLINICAL PHARMACOKINETICS, 1997, 33 (02) :103-121
[3]  
[Anonymous], 2002, GUID IND FOOD EFF BI
[4]  
Center for Drug Evaluation and Research Food and Drug Administration, 2002, GUIDANCE IND FOOD EF
[5]   The Pharmacokinetic and Safety Profiles of Blonanserin in Healthy Chinese Volunteers After Single Fasting Doses and Single and Multiple Postprandial Doses [J].
Chen, Xia ;
Wang, Hongyun ;
Jiang, Ji ;
Chen, Rui ;
Zhou, Ying ;
Zhong, Wen ;
Liu, Hongzhong ;
Hu, Pei .
CLINICAL DRUG INVESTIGATION, 2014, 34 (03) :213-222
[6]  
Dainippon Sumitomo Pharma Co. Ltd, 2016, LON BLON PHARM INT F
[7]   Blonanserin A Review of its Use in the Management of Schizophrenia [J].
Deeks, Emma D. ;
Keating, Gillian M. .
CNS DRUGS, 2010, 24 (01) :65-84
[8]  
FDA, 2012, Guidance for Industry: Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations
[9]   Drug interactions with grapefruit juice - Extent, probable mechanism and clinical relevance [J].
Fuhr, U .
DRUG SAFETY, 1998, 18 (04) :251-272
[10]   Intestinal drug transporter expression and the impact of grapefruit juice in humans [J].
Glaeser, H. ;
Bailey, D. G. ;
Dresser, G. K. ;
Gregor, J. C. ;
Schwarz, U. I. ;
McGrath, J. S. ;
Jolicoeur, E. ;
Lee, W. ;
Leake, B. F. ;
Tirona, R. G. ;
Kim, R. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (03) :362-370